tradingkey.logo

Zentek Ltd

ZTEK
0.702USD
+0.001+0.14%
Close 12/26, 16:00ETQuotes delayed by 15 min
73.58MMarket Cap
LossP/E TTM

Zentek Ltd

0.702
+0.001+0.14%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Zentek Ltd

Currency: USD Updated: 2025-12-24

Key Insights

Zentek Ltd's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 229/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Zentek Ltd's Score

Industry at a Glance

Industry Ranking
229 / 404
Overall Ranking
455 / 4562
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Zentek Ltd Highlights

StrengthsRisks
Zentek Ltd. is an intellectual property technology company. The Company is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The Company is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The Company has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The Company is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 777.99% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 639.66K.
Undervalued
The company’s latest PE is -12.38, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.62M shares, decreasing 15.69% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 10.65.

Financial Health

Currency: USD Updated: 2025-12-24

The current financial score of Zentek Ltd is 5.31, ranking 386/404 in the Biotechnology & Medical Research industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 4.42K, representing a year-over-year decrease of 71.82%, while its net profit experienced a year-over-year decrease of 44.04%.

Score

Industry at a Glance

Previous score
5.31
Change
0

Financials

4.96

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.00

Operational Efficiency

2.83

Growth Potential

4.69

Shareholder Returns

7.07

Zentek Ltd's Company Valuation

Currency: USD Updated: 2025-12-24

The current valuation score of Zentek Ltd is 7.31, ranking 145/404 in the Biotechnology & Medical Research industry. Its current P/E ratio is -12.38, which is -70.25% below the recent high of -3.68 and -47.50% above the recent low of -18.26.

Score

Industry at a Glance

Previous score
7.31
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 229/404
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-24

No earnings forecast score is currently available for Zentek Ltd. The Biotechnology & Medical Research industry's average is 8.02.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-24

The current price momentum score of Zentek Ltd is 6.53, ranking 246/404 in the Biotechnology & Medical Research industry. Currently, the stock price is trading between the resistance level at 0.80 and the support level at 0.62, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.41
Change
0.12

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(5)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.008
Neutral
RSI(14)
44.779
Neutral
STOCH(KDJ)(9,3,3)
56.364
Neutral
ATR(14)
0.044
High Vlolatility
CCI(14)
-29.187
Neutral
Williams %R
47.949
Neutral
TRIX(12,20)
-0.406
Sell
StochRSI(14)
8.841
Sell
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
0.722
Sell
MA10
0.698
Buy
MA20
0.719
Sell
MA50
0.769
Sell
MA100
0.795
Sell
MA200
1.017
Sell

Institutional Confidence

Currency: USD Updated: 2025-12-24

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Fenton (Gregory)
3.14M
+1.25%
Dube (Francis Jacques)
1.14M
+26.81%
Scotia Capital Inc.
898.70K
-0.28%
Van der Kuur (Colin Stuart)
571.33K
--
Wallman (Eric)
475.97K
--
RBC Dominion Securities, Inc.
88.75K
+5.65%
Wood (Peter)
237.72K
--
Shacklock (Ryan)
178.20K
--
Desjardins Securities Inc.
147.18K
--
CIBC World Markets Inc.
141.25K
+13.68%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-24

The current risk assessment score of Zentek Ltd is 1.77, ranking 302/404 in the Biotechnology & Medical Research industry. The company's beta value is 0.42. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
1.77
Change
0
Beta vs S&P 500 index
0.42
VaR
+6.44%
240-Day Maximum Drawdown
+64.04%
240-Day Volatility
+110.11%

Return

Best Daily Return
60 days
+13.61%
120 days
+34.75%
5 years
+34.75%
Worst Daily Return
60 days
-5.85%
120 days
-11.52%
5 years
-17.45%
Sharpe Ratio
60 days
-0.25
120 days
-0.73
5 years
+0.02

Risk Assessment

Maximum Drawdown
240 days
+64.04%
3 years
+68.00%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.51
3 years
-0.28
5 years
--
Skewness
240 days
+2.31
3 years
+2.10
5 years
+1.46

Volatility

Realised Volatility
240 days
+110.11%
5 years
--
Standardised True Range
240 days
+12.58%
5 years
--
Downside Risk-Adjusted Return
120 days
-168.02%
240 days
-168.02%
Maximum Daily Upside Volatility
60 days
+69.39%
Maximum Daily Downside Volatility
60 days
+40.32%

Liquidity

Average Turnover Rate
60 days
+0.30%
120 days
+0.17%
5 years
--
Turnover Deviation
20 days
+1065.19%
60 days
+339.23%
120 days
+154.11%

Peer Comparison

Biotechnology & Medical Research
Zentek Ltd
Zentek Ltd
ZTEK
4.21 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amicus Therapeutics Inc
Amicus Therapeutics Inc
FOLD
8.82 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
IQVIA Holdings Inc
IQVIA Holdings Inc
IQV
8.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Dynavax Technologies Corp
Dynavax Technologies Corp
DVAX
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals Inc
BCRX
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Krystal Biotech Inc
Krystal Biotech Inc
KRYS
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Zentek Ltd?

The TradingKey Stock Score provides a comprehensive assessment of Zentek Ltd based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Zentek Ltd’s performance and outlook.

How do we generate the financial health score of Zentek Ltd?

To generate the financial health score of Zentek Ltd, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Zentek Ltd's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Zentek Ltd.

How do we generate the company valuation score of Zentek Ltd?

To generate the company valuation score of Zentek Ltd, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Zentek Ltd’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Zentek Ltd’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Zentek Ltd.

How do we generate the earnings forecast score of Zentek Ltd?

To calculate the earnings forecast score of Zentek Ltd, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Zentek Ltd’s future.

How do we generate the price momentum score of Zentek Ltd?

When generating the price momentum score for Zentek Ltd, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Zentek Ltd’s prices. A higher score indicates a more stable short-term price trend for Zentek Ltd.

How do we generate the institutional confidence score of Zentek Ltd?

To generate the institutional confidence score of Zentek Ltd, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Zentek Ltd’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Zentek Ltd.

How do we generate the risk management score of Zentek Ltd?

To assess the risk management score of Zentek Ltd, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Zentek Ltd’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Zentek Ltd.
KeyAI